Noevir Holdings Co., Ltd. (TYO:4928)
4,875.00
+5.00 (0.10%)
Aug 21, 2026, 3:30 PM JST
Noevir Holdings Revenue
Noevir Holdings had revenue of 15.46B JPY in the quarter ending June 30, 2026, with 1.40% growth. This brings the company's revenue in the last twelve months to 63.52B, up 1.03% year-over-year. In the fiscal year ending September 30, 2025, Noevir Holdings had annual revenue of 64.72B with 1.41% growth.
Revenue (ttm)
63.52B
Revenue Growth
+1.03%
P/S Ratio
2.62
Revenue / Employee
46.91M
Employees
1,354
Market Cap
166.34B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 64.72B | 901.00M | 1.41% |
| Sep 30, 2024 | 63.82B | 1.27B | 2.03% |
| Sep 30, 2023 | 62.55B | 1.41B | 2.30% |
| Sep 30, 2022 | 61.14B | 9.87B | 19.25% |
| Sep 30, 2021 | 51.27B | -569.00M | -1.10% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KOSE Holdings | 334.58B |
| Cawachi | 285.45B |
| Genky DrugStores | 220.64B |
| Earth | 185.57B |
| Pola Orbis Holdings | 171.38B |
| Kobayashi Pharmaceutical | 167.47B |
| MTG Co., Ltd. | 131.24B |
| Pigeon | 114.41B |